OBJECTIVES
Studies on drug survival provide real-world data on efficacy as well as safety. We aimed to evaluate the long-term drug survival of adalimumab (ADA) in a large cohort of patients with Behçet's syndrome (BS).
METHODS
We conducted a retrospective chart review of 335 BS patients who started ADA between 2008 a...
Ozge Sonmez, S. N. Esatoğlu, D. Uçar et al.· Rheumatology· 0 citations
This critical review aims to highlight the publications on Behçet's syndrome (BS) during 2025. Recent studies have further elucidated the immunopathogenesis of BS, highlighting the interplay between innate and adaptive immune responses. Neutrophil hyperactivation, macrophage heterogeneity, and T cell imbalance emerge a...
G. Hatemi, E. Seyahi, I. Fresko et al.· Clinical and Experimental Rh...· 0 citations
OBJECTIVES
Increased intestinal permeability has been implicated in the pathogenesis of autoimmune and inflammatory conditions, including Behçet syndrome (BS). Zonulin, an endogenous regulator of intestinal tight junctions, serves as a biomarker for assessing intestinal barrier integrity. We aimed to evaluate intestina...
Mustafa Erdoğan, F. Ozbakır, B. Yurttaş et al.· Clinical and Experimental Rh...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.